S
Sygnature Discovery
Biotech & Life Sciences · Nottingham, United Kingdom · Founded 2004 Thoroughbred
Investors
1 investor on Sygnature Discovery's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where Sygnature Discovery has talent and traffic
(5 of 650 staff)
team presence
across markets
Capital deployed
Sygnature Discovery's 5 investments and acquisitions.
Every disclosed deal where Sygnature Discovery appeared as a backer or acquirer, 2017–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across Sygnature Discovery's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Sygnature Discovery's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Sygnature Discovery
An AI-synthesized read of the highest-engagement posts about Sygnature Discovery on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sygnature Discovery on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.